Ethyl 4-(bromomethyl)benzoate → HCID 66818755, 화합물

반응식

[CH2:1]([O:3][C:4]([N:6]1[CH2:11][CH2:10][N:9]([C:12](=[O:29])[C:13]2[CH:18]=[C:17]([OH:19])[CH:16]=[C:15]([O:20][C:21]3[CH:26]=[CH:25][C:24]([C:27]#[N:28])=[CH:23][CH:22]=3)[CH:14]=2)[CH2:8][CH2:7]1)=[O:5])[CH3:2].[CH2:30]([O:32][C:33](=[O:42])[C:34]1[CH:39]=[CH:38][C:37]([CH2:40]Br)=[CH:36][CH:35]=1)[CH3:31]>>[CH2:1]([O:3][C:4]([N:6]1[CH2:11][CH2:10][N:9]([C:12](=[O:29])[C:13]2[CH:18]=[C:17]([O:19][CH2:40][C:37]3[CH:36]=[CH:35][C:34]([C:33]([O:32][CH2:30][CH3:31])=[O:42])=[CH:39][CH:38]=3)[CH:16]=[C:15]([O:20][C:21]3[CH:26]=[CH:25][C:24]([C:27]#[N:28])=[CH:23][CH:22]=3)[CH:14]=2)[CH2:8][CH2:7]1)=[O:5])[CH3:2]

참가 물질

반응물 2

HCID 954261Ethyl 4-(bromomethyl)benzoate

HCID 66818527HCID 66818527, 화합물

생성물 1

HCID 66818755HCID 66818755, 화합물수율 83.5%

실험 절차

Using 0.52 g (1.31 mmol) of 4-[3-(4-cyano phenoxy)-5-hydroxy benzoyl]-piperazine-1-carboxylic acid ethyl ester and 4-bromomethyl-benzoic acid ethyl ester (0.318 g, 1.31 mmol) and following the procedure of Example 42(b) affored 0.61 g of the required product. Percentage purity (LCMS): 60.0% (M+1)=557.2+1.

출처 및 근거

ORD 기록: ord-aecae1de0ab84bd0a5fee142e3aab992
출처 데이터셋: uspto-grants-2014_05
DOI: 10.6084/m9.figshare.5104873.v1
특허 번호: US08722930B2

반응 노트

불러오는 중…